Tools for Assessment of the Appropriateness of Prescribing and Association with Patient-Related Outcomes: A Systematic Review
There are tools and criteria in the literature aimed at distinguishing between appropriate and inappropriate medicines use. However, many have not been externally validated with regard to patient-related outcomes, potentially limiting their use in clinical practice.
The aim of the study was to conduct a systematic review to summarise (1) available prescribing appropriateness assessment tools and criteria, and (2) their associations with patient-related outcomes (external validity).
A systematic review was conducted using MEDLINE, EMBASE and Informit (Health Collection) databases to screen for articles in English that examined (1) tools to assess the appropriateness of prescribing and (2) associations of tools with patient-related outcomes, published between 2000 and 2016, without any limits placed on the study design, participant age or setting.
After screening 1710 articles, removing duplicates and shortlisting relevant articles, 42 prescribing assessment tools were identified. Out of the 42 tools, 78.6% (n = 33) provided guidance around stopping inappropriate medications, 28.6% (n = 12) around starting appropriate medications, 61.9% (n = 26) were explicit (criteria based) and 31.0% (n = 13) had been externally validated, with hospitalisation being the most commonly used patient-related outcome (n = 9, 21.4%).
The results of this systematic review highlight the need for evidence-based and externally validated tools, which combine the different aspects of medication management to optimise patient-related outcomes. PROSPERO registration number: CRD42017067233.
Compliance with Ethical Standards
Nashwa Masnoon is supported by an Australian Government Research Training Program (RTP). No other sources of funding were used to assist in the preparation of this article.
Conflicts of interest
Nashwa Masnoon, Sepehr Shakib, Lisa Kalisch-Ellett and Gillian Caughey declare that they have no conflicts of interest relevant to the content of this review.
- 18.NPS MEDICINEWISE. Identifying inappropriate prescribing. In: Older people & medicines. 2013. http://www.nps.org.au/topics/ages-life-stages/for-individuals/older-people-and-medicines/for-health-professionals/inappropriate-prescribing. Accessed 15 March 2017.
- 26.CASP UK. CASP Checklists. In: Critical Appraisal Skills Programme (CASP) Making sense of evidence. CASP UK. 2017. https://www.casp-uk.net/casp-tools-checklists. Accessed 10 May 2017.
- 28.Tommelein E, Petrovic M, Somers A, et al. Older patients’ prescriptions screening in the community pharmacy: development of the Ghent Older People’s Prescriptions community Pharmacy Screening (GheOP3S) tool. J Public Health (Oxf). 2016;38(2):e158–70. https://doi.org/10.1093/pubmed/fdv090.CrossRefGoogle Scholar
- 32.Niehoff KM, Rajeevan N, Charpentier PA, et al. Development of the tool to reduce inappropriate medications (TRIM): a clinical decision support system to improve medication prescribing for older adults. Pharmacotherapy. 2016;36(6):694–701. https://doi.org/10.1002/phar.1751.PubMedPubMedCentralCrossRefGoogle Scholar
- 34.PrescQIPP. Optimising safe and appropriate medicines use. 2017. https://www.prescqipp.info/projects/optimising-safe-and-appropriate-medicines-use. Accessed 2 Nov 2017.
- 37.Kojima T, Mizukami K, Tomita N, et al. Screening tool for older persons’ appropriate prescriptions for Japanese: Report of the Japan Geriatrics Society Working Group on “Guidelines for Medical Treatment and its Safety in the Elderly”. Geriatr Gerontol Int. 2016;16(9):983–1001. https://doi.org/10.1111/ggi.12890.PubMedCrossRefGoogle Scholar
- 38.Maio V, Del Canale S, Abouzaid S. Using explicit criteria to evaluate the quality of prescribing in elderly Italian outpatients: a cohort study. J Clin Pharm Ther. 2010;35(2):219–29. https://doi.org/10.1111/j.1365-537(2710).2009.01094.x.PubMedCrossRefGoogle Scholar
- 39.Renom-Guiteras A, Meyer G, Thürmann PA. The EU(7)-PIM List: a list of potentially inappropriate medications for older people consented by experts from seven European countries. Eur J Clin Pharmacol. 2015;71(7):861–75. https://doi.org/10.1007/s00228-015-1860-9.PubMedPubMedCentralCrossRefGoogle Scholar
- 45.Drenth-van Maanen AC, van Marum RJ, Knol W, et al. Prescribing optimization method for improving prescribing in elderly patients receiving polypharmacy: results of application to case histories by general practitioners. Drugs Aging. 2009;26(8):687–701. https://doi.org/10.2165/11316400-000000000-00000.PubMedCrossRefGoogle Scholar
- 47.Haque RM. ARMOR: a tool to evaluate polypharmacy in elderly persons. Ann Long-Term Care. 2009;17(6):26–30.Google Scholar
- 50.National Committee for Quality Assurance. HEDIS 2016. 2016.Google Scholar
- 51.Van der Linden L, Decoutere L, Flamaing J, et al. Development and validation of the RASP list (Rationalization of Home Medication by an Adjusted STOPP list in Older Patients): a novel tool in the management of geriatric polypharmacy. Eur Geriatr Med. 2014;5(3):175–80. https://doi.org/10.1016/j.eurger.2013.12.005.CrossRefGoogle Scholar
- 66.Henschel F, Redaelli M, Siegel M, et al. Correlation of incident potentially inappropriate medication prescriptions and hospitalization: an analysis based on the PRISCUS list. Drugs Real World Outcomes. 2015;2(3):249–59. https://doi.org/10.1007/s40801-015-0035-4.PubMedPubMedCentralCrossRefGoogle Scholar
- 67.Frankenthal D, Lerman Y, Kalendaryev E, et al. Intervention with the screening tool of older persons potentially inappropriate Prescriptions/Screening Tool to Alert doctors to Right Treatment criteria in elderly residents of a chronic geriatric facility: a randomized clinical trial. J Am Geriatr Soc. 2014;62(9):1658–65. https://doi.org/10.1111/jgs.12993.PubMedCrossRefGoogle Scholar
- 68.Moriarty F, Bennett K, Cahir C, et al. Potentially inappropriate prescribing according to STOPP and START and adverse outcomes in community-dwelling older people: a prospective cohort study. Br J Clin Pharmacol. 2016;82(3):849–57. https://doi.org/10.1111/bcp.12995.PubMedPubMedCentralCrossRefGoogle Scholar
- 72.Maggiore RJ, Dale W, Gross CP, et al. Polypharmacy and potentially inappropriate medication use in older adults with cancer undergoing chemotherapy: effect on chemotherapy-related toxicity and hospitalization during treatment. J Am Geriatr Soc. 2014;62(8):1505–12. https://doi.org/10.1111/jgs.12942.PubMedPubMedCentralCrossRefGoogle Scholar
- 73.Price SD, Holman CD, Sanfilippo FM, et al. Impact of specific Beers criteria medications on associations between drug exposure and unplanned hospitalisation in elderly patients taking high-risk drugs: a case-time-control study in Western Australia. Drugs Aging. 2014;31(4):311–25. https://doi.org/10.1007/s40266-014-0164-6.PubMedCrossRefGoogle Scholar
- 78.Pasina L, Djade CD, Tettamanti M, et al. Prevalence of potentially inappropriate medications and risk of adverse clinical outcome in a cohort of hospitalized elderly patients: results from the REPOSI study. J Clin Pharm Ther. 2014;39(5):511–5. https://doi.org/10.1111/jcpt.12178.PubMedCrossRefGoogle Scholar
- 82.Lund BC, Carnahan RM, Egge JA, et al. Inappropriate prescribing predicts adverse drug events in older adults. Ann Pharmacother. 2010;44(6):957–63. https://doi.org/10.1345/aph.1M65710.1345/aph.1M657A.PubMedCrossRefGoogle Scholar
- 88.Fox C, Richardson K, Maidment ID, et al. Anticholinergic medication use and cognitive impairment in the older population: the medical research council cognitive function and ageing study. J Am Geriatr Soc. 2011;59(8):1477–83. https://doi.org/10.1111/j.1532-5415.2011.03491.x.PubMedCrossRefGoogle Scholar
- 89.Pasina L, Djade CD, Lucca U, et al. Association of anticholinergic burden with cognitive and functional status in a cohort of hospitalized elderly: comparison of the anticholinergic cognitive burden scale and anticholinergic risk scale: results from the REPOSI study. Drugs Aging. 2013;30(2):103–12. https://doi.org/10.1007/s40266-012-0044-x.PubMedCrossRefGoogle Scholar
- 93.Lowry E, Woodman RJ, Soiza RL, et al. Associations between the anticholinergic risk scale score and physical function: potential implications for adverse outcomes in older hospitalized patients. J Am Med Dir Assoc. 2011;12(8):565–72. https://doi.org/10.1016/j.jamda.2011.03.006.PubMedCrossRefGoogle Scholar
- 95.Kersten H, Molden E, Willumsen T, et al. Higher anticholinergic drug scale (ADS) scores are associated with peripheral but not cognitive markers of cholinergic blockade. Cross sectional data from Norwegian nursing homes. Br J Clin Pharmacol. 2013;75(3):842–9. https://doi.org/10.1111/j.1365-2125.2012.04411.x.PubMedPubMedCentralCrossRefGoogle Scholar
- 101.Mangoni AA, van Munster BC, Woodman RJ, et al. Measures of anticholinergic drug exposure, serum anticholinergic activity, and all-cause postdischarge mortality in older hospitalized patients with hip fractures. Am J Geriatr Psychiatry. 2013;21(8):785–93. https://doi.org/10.1016/j.jagp.2013.01.012.PubMedCrossRefGoogle Scholar
- 117.Wang KCM, Veluswamy R. Evidence-based strategies to reduce polypharmacy: a review. OA Elderly Med. 2013;1:6.Google Scholar
- 122.Hill-Taylor B, Walsh KA, Stewart S, et al. Effectiveness of the STOPP/START (Screening Tool of Older persons’ Potentially inappropriate Prescriptions/Screening Tool to Alert doctors to the Right Treatment) criteria: systematic review and meta-analysis of randomized controlled studies. J Clin Pharm Ther. 2016;41(2):158–69. https://doi.org/10.1111/jcpt.12372.PubMedCrossRefGoogle Scholar
- 124.Australian Medicines Handbook Pty Ltd. Prescribing for the elderly. In: The Australian Medicines Handbook. Australian Medicines Handbook Pty Ltd. 2017. https://amhonline-amh-net-au.access.library.unisa.edu.au/guides/guide-elderly. Accessed 10 May 2017.